UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
KELVIN MEDICAL, INC
(Exact name of registrant as specified in its charter)
| Nevada | 81-2552488 | |
| (State of incorporation or organization) | (I.R.S. Employer Identification No.) | |
10930 Skyranch Place Nevada City, CA 95959 | ||
| (Address of principal executive offices) (Zip Code) | ||
Securities to be registered pursuant to Section 12(b) of the Act: None
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. [ ]
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A. (d), check the following box. [X]
Securities Act registration statement file number to which this form relates: File No. 333-212791 (if applicable)
Securities to be registered pursuant to Section 12(g) of the Act: common stock, $0.001 par value
Item 1. Description of Registrant's Securities to be Registered.
The following description of the authorized capital stock of Kelvin Medical, Inc. (the "Company") does not purport to be complete and is subject to and qualified in its entirety by its Articles of Incorporation, which is included as an exhibit to the Company's Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 1, 2016 and subject to the applicable provisions of the Nevada Revised Statutes.
The Company is authorized to issue 100,000,000 shares of common stock, par value $0.001 per share, of which 64,097,500 shares are issued and outstanding as of October 13, 2017. Each holder of shares of our common stock is entitled to one vote for each share held of record on all matters submitted to the vote of shareholders, including the election of directors. The holders of shares of common stock have no preemptive, conversion, subscription or cumulative voting rights. There is no provision in our Articles of Incorporation or By-laws that would delay, defer or prevent a change in control of our company.
Item 2. Exhibits.
| Exhibit No. | Description |
| 3.1 | Articles of Incorporation (1) |
| (1) | Incorporated herein by reference to Exhibit 3.1 to the Company's Registration Statement on Form S-1, filed with the SEC on August 1, 2016. |
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities and Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
KELVIN MEDICAL, INC. | |
| Date: October 13, 2017 | By: /s/William Mandel |
Name: William Mandel Title: Chief Executive Officer | |